Nevro Corp. (NVRO)

11,32 -0,30 (-2,58%) Al cierre: 04:00PM EDT

Nevro Corp.

1800 Bridge Parkway
Redwood City, CA 94065
United States
650 251 0005
https://nevro.com

Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 1215

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Kevin R. Thornal	President, CEO & Director	1,37M	N/A	1974
Mr. Roderick H. MacLeod	Senior VP & CFO	653,1k	N/A	1967
Mr. Kashif Rashid	Senior VP of Corporate Development & Chief Legal Officer	629,62k	N/A	1974
Mr. Greg Siller	Senior VP & Chief Commercial Officer	419,9k	N/A	1981
Mr. Richard B. Carter	Chief Accounting Officer	N/A	N/A	1971
Mr. Christofer Christoforou	Senior Vice President of Technical Operations	367,4k	N/A	1970
Geeta Kaveti	VP and Chief Compliance & Privacy Officer	N/A	N/A	N/A
Meredith Vornholt	Vice President of Global Marketing	N/A	N/A	N/A
Ms. Shana D. Ross M.B.A.	Senior VP & Chief Human Resources Officer	N/A	N/A	1973
Dr. David Caraway M.D., Ph.D.	Senior VP & Chief Medical Officer	N/A	N/A	1957

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.

Gobierno corporativo

El ISS Governance QualityScore de Nevro Corp., a día 1 de abril de 2024, es 8. Las puntuaciones base son Auditoría: 6; Tablero: 7; Derechos de los accionistas: 4; Compensación: 10.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.